Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Venn

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Plos One|October 23, 2013
Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual diseaseMawar Karsa, Luciano Dalla Pozza, Nicola C Venn, et al.
Oncotarget|July 16, 2016
COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemiaBruno Almeida Lopes, Claus Meyer, Thayana Conceição Barbosa, et al.
Oncotarget|September 14, 2016
Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemiaBabasaheb D Yadav, Amy L Samuels, Julia E Wells, et al.
Molecular Cancer Research : MCR|November 15, 2017
Targeted Next-Generation Sequencing for Detecting <i>MLL</i> Gene Fusions in LeukemiaSadia Afrin, Christine R C Zhang, Claus Meyer, et al.
Leukemia|May 23, 2008
Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-kappa and heavy-chain gene rearrangementsR Sutton, A Y Bahar, E Kwan, et al.
British Journal of Haematology|October 15, 2014
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaRosemary Sutton, Peter J Shaw, Nicola C Venn, et al.
Blood|March 21, 2007
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subcloneSeoyeon Choi, Michelle J Henderson, Edward Kwan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
Effective targeting of the P53-MDM2 axis in preclinical models of infant MLL-rearranged acute lymphoblastic leukemiaJennifer Richmond, Hernan Carol, Kathryn Evans, et al.
Bone Marrow Transplantation|May 17, 2016
Xenograft-directed personalized therapy for a patient with post-transplant relapse of ALLT N Trahair, R B Lock, R Sutton, et al.
Blood|March 24, 2017
Monitoring of childhood ALL using <i>BCR-ABL1</i> genomic breakpoints identifies a subgroup with CML-like biologyLenka Hovorkova, Marketa Zaliova, Nicola C Venn, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Plos One|October 23, 2013
Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual diseaseMawar Karsa, Luciano Dalla Pozza, Nicola C Venn, et al.
Oncotarget|July 16, 2016
COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemiaBruno Almeida Lopes, Claus Meyer, Thayana Conceição Barbosa, et al.
Oncotarget|September 14, 2016
Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemiaBabasaheb D Yadav, Amy L Samuels, Julia E Wells, et al.
Molecular Cancer Research : MCR|November 15, 2017
Targeted Next-Generation Sequencing for Detecting <i>MLL</i> Gene Fusions in LeukemiaSadia Afrin, Christine R C Zhang, Claus Meyer, et al.
Leukemia|May 23, 2008
Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-kappa and heavy-chain gene rearrangementsR Sutton, A Y Bahar, E Kwan, et al.
British Journal of Haematology|October 15, 2014
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaRosemary Sutton, Peter J Shaw, Nicola C Venn, et al.
Blood|March 21, 2007
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subcloneSeoyeon Choi, Michelle J Henderson, Edward Kwan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
Effective targeting of the P53-MDM2 axis in preclinical models of infant MLL-rearranged acute lymphoblastic leukemiaJennifer Richmond, Hernan Carol, Kathryn Evans, et al.
Bone Marrow Transplantation|May 17, 2016
Xenograft-directed personalized therapy for a patient with post-transplant relapse of ALLT N Trahair, R B Lock, R Sutton, et al.
Blood|March 24, 2017
Monitoring of childhood ALL using <i>BCR-ABL1</i> genomic breakpoints identifies a subgroup with CML-like biologyLenka Hovorkova, Marketa Zaliova, Nicola C Venn, et al.
Pageof 5